Edition:
India

DarioHealth Corp (DRIO.OQ)

DRIO.OQ on NASDAQ Stock Exchange Capital Market

18.95USD
18 Sep 2020
Change (% chg)

-- (--)
Prev Close
$18.95
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
48,338
52-wk High
$22.34
52-wk Low
$3.03

Select another date:

Mon, Jun 15 2020

BRIEF-DarioHealth Presents Studies Showing Improvements In Blood Glucose & Blood Pressure Control

* DARIOHEALTH PRESENTS NEW STUDIES DEMONSTRATING SUSTAINED IMPROVEMENTS IN BLOOD GLUCOSE AND BLOOD PRESSURE CONTROL IN USERS WITH DIABETES AND HYPERTENSION AT THE AMERICAN DIABETES ASSOCIATION'S 80TH SCIENTIFIC SESSIONS Source text for Eikon: Further company coverage:

BRIEF-DarioHealth Announces Two Remote Patient Monitoring Agreements And Commences Enrollment

* DARIOHEALTH ANNOUNCES TWO REMOTE PATIENT MONITORING (RPM) AGREEMENTS AND COMMENCES ENROLLMENT Source text for Eikon: Further company coverage:

BRIEF-Dariohealth Corp Posts Q1 Loss Per Share Of $1.57

* REVENUES FOR Q1 ENDED MARCH 31, 2020 WERE $1.67 MILLION, A 7.3% SEQUENTIAL DECREASE FROM Q4 ENDED DECEMBER 31, 2019

BRIEF-Dariohealth Corp - FDA Recognized Home-Use Blood Glucose Meters May Be Used By Patients With Diabetes Who Are Hospitalized Due To COVID-19

* DARIOHEALTH CORP - FDA RECOGNIZED HOME-USE BLOOD GLUCOSE METERS MAY BE USED BY PATIENTS WITH DIABETES WHO ARE HOSPITALIZED DUE TO COVID-19 Source text for Eikon: Further company coverage:

BRIEF-Dariohealth Enters Partnership With Vitality To Accelerate Penetration Into Self-Insured Employer Market

* DARIOHEALTH ENTERS INTO A PARTNERSHIP WITH VITALITY TO ACCELERATE PENETRATION INTO THE SELF-INSURED EMPLOYER MARKET Source text for Eikon: Further company coverage:

Select another date: